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Understanding brain energy metabolism—neuroenergetics—is becoming increasingly
important as it can be identified repeatedly as the source of neurological perturbations.
Within the scientific community we are seeing a shift in paradigms from the traditional
neurocentric view to that of a more dynamic, integrated one where astrocytes are no
longer considered as being just supportive, and activated microglia have a profound
influence. Lactate is emerging as the “good guy,” contrasting its classical “bad guy”
position in the now superseded medical literature. This review begins with the evolution
of the concept of “lactate shuttles”; goes on to the recent shift in ideas regarding normal
neuroenergetics (homeostasis)—specifically, the astrocyte–neuron lactate shuttle; and
progresses to covering the metabolic implications whereby homeostasis is lost—a
state of allostasis, and the function of microglia. The role of lactate, as a substrate
and shuttle, is reviewed in light of allostatic stress, and beyond—in an acute state
of allostatic stress in terms of physical brain trauma, and reflected upon with respect
to persistent stress as allostatic overload—neurodegenerative diseases. Finally, the
recently proposed astrocyte–microglia lactate shuttle is discussed in terms of chronic
neuroinflammatory infectious diseases, using tuberculous meningitis as an example. The
novelty extended by this review is that the directionality of lactate, as shuttles in the brain,
in neuropathophysiological states is emerging as crucial in neuroenergetics.
Keywords: neuroenergetics, lactate, astrocyte-neuron lactate shuttle (ANLS), astrocyte-microglia lactate shuttle
(AMLS), neuropathology, traumatic brain injury (TBI), neurodegenerative disease, infectious neuroinflammatory
disease
INTRODUCTION
The human brain represents approximately 2% of total body weight and receives up to 15%
of total blood flow, consuming up to 20% of oxygen and 25% of circulating glucose under
normal conditions (Pellerin, 2010). The metabolism of this high energy consuming organ involves
complex intercellular trafficking of metabolites and compartmentalization of numerous processes.
Tight coupling exists between the supply and demand of energy in brain metabolism with
changes in cerebral blood flow and glucose utilization in response to neuronal activity (i.e.,
neurovascular and neurometabolic coupling) (Bélanger et al., 2011) under normal homeostatic
conditions. Mechanisms involved in brain energy metabolism adapt during periods of perturbation
and trauma. The important role of lactate, and its shuttles, has been overlooked and merits
acknowledgement.
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The interconversion of lactate and pyruvate occurs via lactate
dehydrogenase, with increased lactate typically being associated
with anaerobic respiration. Thus, one could postulate that
elevated levels of lactate present in the cerebrospinal fluid (CSF)
due to neuroinflammation could be from hypoxia caused by
ischemia—increased anaerobic respiration (Rossi et al., 2007),
or by raised glucose levels and hence elevated flow through the
glycolysis pathway. However, in most neuroinflammatory cases
there are typically periods of low levels of glucose in the CSF.
Furthermore, several studies have shown no correlation between
CSF lactate levels and cerebral blood flow (i.e., they are unrelated
to ischemia) (Brodersen and Jorgensen, 1974; DeSalles et al.,
1986; De Salles et al., 1987). Thus, an alternative postulate is that
the elevated levels of lactate in the CSF of neuroinflammatory
cases is unlikely to be due to anaerobic respiration but instead is
possibly a product of temporarily increased flux in the glycolysis
pathway—using glycogen as a supplementary source of glucose.
The notion that lactate is not simply just a by-product of
glycolysis but also a shuttle system was pioneered by Brooks
(1985). In June the following year, Brooks provided more
evidence for a “shuttling” system for lactate (Brooks, 1986a);
by December Brooks (1986b) formally coined the term “lactate
shuttle” in skeletal muscle during rest and exercise under
fully aerobic conditions. Brooks further defined lactate shuttles
as being either intracellular (cytosolic to mitochondrial) or
cell-to-cell (extracellular) (Brooks, 2000, 2002). Later, Brooks
(2009) provided evidence that glycolytic and oxidative pathways
should be viewed as linked, as opposed to alternative processes,
because lactate, the product of one pathway, is the substrate for
the other (Brooks, 2009). The concept of intracellular lactate
shuttles was challenged (Sahlin et al., 2002), and continues to
be so (Laureys et al., 2014). A study by Cruz et al. (2012)
discussed these challenges but ultimately reiterated Brooks’
sentiment regarding interaction between energy systems—the
product of one is the substrate of another. Soon after Brooks
first introduced the concept of lactate shuttles in 1986, several
studies by Schurr et al. (1988, 1997a,b,c, 1999a,b) provided
experimental evidence that astrocytic lactate is even used
preferentially over glucose by neurons after episodes of cerebral
ischemia.
Thus, lactate plays an important role as a shuttle, even beyond
the brain—in numerous systems, for example, in pregnancy (Zuo
et al., 2015), in reproduction (Kuchiiwa et al., 2011), and, notably,
within the human heart (Cruz et al., 2012; Rakus et al., 2016).
This paper provides an overview of brain neuroenergetics and the
crucial roles of lactate shuttles. These roles will be discussed: (1)
with regard to the normal physiological function and relationship
between astrocytes and neurons (homeostasis)—the astrocyte–
neuron lactate shuttle (ANLS) model; (2) the dynamic role
of microglia and their preferential utilization of lactate under
perturbed conditions (allostasis); (3) the activity of lactate and
its shuttles in neuropathological states (in particular in traumatic
brain injury and neurodegenerative diseases); and (4) the
brain in crisis—in response to a neuroinflammatory infectious
disease—according to the astrocyte–microglia lactate shuttle




The classical view of neuroenergetics is that the blood supplies
oxygen and glucose to the brain (Sokoloff, 1989). Glucose is
the primary source of energy utilized by both neurons and
astrocytes. It undergoes complete oxidation via glycolysis, the
Krebs cycle and oxidative phosphorylation, which ultimately
produces adenosine triphosphate (ATP) for energy-dependent
reactions. Thus, glucose is used in the same way by all cell types.
Since neurons consume the greatest quantity of energy of all
brain elements, metabolic intermediates (e.g., in the Krebs cycle)
are diverted toward neurons. Some of the pyruvate produced
by glycolysis is converted to lactate and released into the
extracellular space. In this classical view, lactate is considered a
by-product with deleterious effects when in excess (Norenberg
et al., 1987; Siesjö, 1988; Bender et al., 1997). Astrocytes have
long been thought to play a passive role in supporting neuronal
function, with the neuron being the star of the show. However,
the dynamic involvement of astrocytes (Ranjbar andAmiri, 2015)
in the forefront of neuroenergetics is now being recognized,
shifting paradigms (Haydon and Carmignoto, 2006; Giaume
et al., 2010). The neurocentric view of neuroenergetics is evolving
into a more integrated one of complementary and co-operative
metabolic interactions between astrocytes and neurons.
Astrocytes–More than a Supporting Role?
At the cellular level the human brain consists of the all-
important neurons and up to 10 times more glial cells than
neurons (Kimelberg and Norenberg, 1989). There are four types
of glial cells: ependymal cells, oligodendrocytes, astrocytes,
and microglia (resident macrophages in the brain). Astrocytes
constitute about 50% of the total human brain volume and are
classically divided into three types based on morphology and
spatial organization. These three types are: (1) radial—orientated
perpendicular to ventricular surfaces with long, unbranched
processes (end-feet); (2) protoplasmic—displaying bushy
morphology with numerous, highly branched, short processes;
and (3) fibrous—manifesting stellate shapes with smooth,
long processes that are less branched. The cytoarchitectural
organization of astrocytes is such that, according to Pellerin
(2010) particular sections cover 99% of the surface area of
cerebral blood vessels; although, due to tissue shrinkage with
chemical fixation (Korogod et al., 2015), this 99% value is
likely an inflated estimate. These astrocytes are, however, the
preferential site for glucose uptake from the blood, as well as
having projections in peri-synaptic areas of neurons, providing
close interaction with neuronal elements and acting as a cellular
barrier between blood and neurons. The unique morphological
and phenotypic characteristics of astrocytes ideally position
them to sense and respond dynamically to changes in neuronal
activity (Pellerin, 2010; Bélanger et al., 2011), lending them to
conduct numerous critical functions (Chen and Swanson, 2003;
Steele and Robinson, 2012), such as glutamate homeostasis
(in the glutamate–glutamine cycle), maintaining brain ionic
equilibrium (K+ and H+ buffering), the maintenance of reactive
oxygen species (ROS) (in glutathione recycling) and osmotic
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regulation. Astrocytes therefore support neuronal activity via
structural, trophic and metabolic means, suggesting a critical
role in regulating neuroenergetics and homeostatic functions
(Pellerin, 2010). Notably, neurons rely on astrocytes to supply
precursors of the Krebs cycle intermediates, or their derivatives,
as the enzyme pyruvate carboxylase is present in only astrocytes
but not in neurons (Hertz et al., 1999).
Astrocytes exhibit a higher capacity for glucose utilization,
as well as greater metabolic plasticity, than neurons;
these characteristics are important for homeostatic and
neuroprotective functions. The calculated energy needs of
astrocytes only represent about 10–15% of the total brain energy
needs (Attwell and Laughlin, 2001; Gjedde et al., 2002; Rothman
et al., 2003; Shulman et al., 2004). Hence, approximately
85% of the glucose in the brain is used in the expenditure of
energy in neurons via the glycolytic pathway and the Krebs
cycle leading to the synthesis of ATP (Jueptner and Weiller,
1995; Attwell and Laughlin, 2001). The high glycolytic rate
of astrocytes suggests a preference for the production and
release of lactate. The neuroprotective role of lactate has been
experimentally demonstrated by studies (Cater et al., 2001, 2003).
Neuroprotection here is defined as an intervention that prevents
the death of vulnerable neurons and slows disease progression.
Hence, evidence that has emerged over the past two decades
has begun to highlight lactate as a supplementary substrate for
neurons, resulting in the (re)emergence of a dynamic nursing
role for astrocytes (Bouzier-Sore et al., 2002).
Astrocyte–Neuron Lactate Shuttle (ANLS)
Hypothesis
Magistretti and Pellerin (1996) presented the framework of
a hypothesis that they have since developed and refined to
become one of the prevailing contemporary viewpoints of
neuroenergetics—the ANLS hypothesis. The hypothesis states
that astrocytes respond to intensified neuron activity by
increasing their rate of glucose uptake, glycolysis and the release
of lactate into the extracellular space, as shown schematically
in Figure 1. At the metabolic level, it begins with glutamatergic
activity, a process whereby increased neuronal activity results in
the release of glutamate, the main excitatory neurotransmitter
in the brain, into the extracellular space along the glutamate
transporter EAAT3, which is exclusively located in neurons.
Astrocytes sense increased activity at the glutamatergic synapses,
followed by glutamate uptake via the glia-specific glutamate
transporters EAAT1 and EAAT2. The transport of glutamate
is driven by a sodium gradient (i.e., by a Na+-dependent
mechanism), with a stoichiometry of three Na+ ions co-
transported with one glutamate, resulting in a significant increase
in intracellular Na+ concentrations in astrocytes (Magistretti
and Pellerin, 1999; Pellerin and Magistretti, 2004; Bélanger
et al., 2011). Glutamate taken up by astrocytes is converted
to glutamine through an ATP-dependent reaction catalyzed by
astrocyte-specific glutamine synthetase. Glutamine is released
back into the extracellular space and taken up by neurons,
where it is converted to glutamate by glutaminase (Magistretti
and Pellerin, 1999; Bélanger et al., 2011). This reaction
thereby replenishes the neurotransmitter pool of glutamate and
completes the glutamate–glutamine cycle. Glutamate uptake
by astrocytes stimulates glucose uptake with a stoichiometric
relationship of 1:1 between uptake of glutamate and glucose.
Increased concentrations of Na+ in astrocytes activate the
enzyme Na+-K+-ATPase, particularly the α2 subunit. The result
is the triggering of glycolysis, leading to the production and
release of lactate into the extracellular space; the lactate is
then taken up as an energy substrate by neurons for oxidative-
derived ATP production (Debernardi et al., 1999; Magistretti
and Pellerin, 1999; Pellerin, 2003; Pellerin and Magistretti, 2004;
Pellerin et al., 2007; Bélanger et al., 2011). This demonstrates the
presence of open astroglial metabolic networks—an intercellular
route, allowing the trafficking of energy substrates through
astrocytes from their source, which is blood vessels, to the site of
high energy demand and use, the neurons (Giaume et al., 2010).
Fox et al. (1988) were the first to show that focal, physiological
increase in neuronal activity induced by visual stimulation in
humans was associated with increased glucose uptake and blood
flow in the human visual cortex. This suggested that increased
neuronal functional activity stimulates glycolysis. Prichard et al.
(1991) and Sappey-Marinier et al. (1992) further developed this
postulate by demonstrating increased levels of lactate in the
human visual cortex using nuclear magnetic resonance (NMR)
technology, following visual stimulation. Thus, a tight coupling
was demonstrated between neuronal activation and glucose
utilization in astrocytes (Magistretti, 2006), an intrinsic feature
of astrocytes not specifically linked to culture conditions or cell
origin (Pellerin et al., 2007). It is interesting to note that glucose
uptake by astrocytes is disproportionately high compared to
their energy requirements. This suggests that sustained astrocytic
glycolysis occurs in order to maintain the extracellular lactate
pool to meet the energy requirements of neurons. Most recently,
data from Angamo et al. (2016) suggest that astrocytic neuronal
lactate shuttles contribute to the regulation of ion homeostasis
and synaptic signaling in the presence of ample glucose.
In addition to blood-borne glucose, the brain also makes
use of an important energy reserve in the form of glycogen
stores located almost exclusively in astrocytes. Mobilization of
glycogen occurs without ATP requirement during extended
periods of limited energy supply (e.g., in hypoglycemia) and leads
to enhanced lactate production and release, thereby maintaining
energetic homeostasis and preserving neuronal function and
viability (Wender et al., 2000; Pellerin, 2003; Pellerin and
Magistretti, 2004). Glycogen mobilization can thus be viewed
as an extension of the ANLS concept instead of a competing
hypothesis (Pellerin et al., 2007). But, as stated by Dienel
and Cruz (2015), glycogen is very difficult to study in the
human brain. Roles for glycogen in brain function continue to
emerge, revealing increasing complexity of the signaling and
regulatory mechanisms that integrate glycogen mobilization with
physiological activities.
It is important to note that the ANLS hypothesis does not
preclude glucose as a source of energy for the brain. Glucose
remains an important energy substrate with concentration
gradients facilitating the transport of glucose across the blood–
brain barrier into the brain via glucose transporters (GLUTs).
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FIGURE 1 | Schematic representation of the astrocyte-neuron lactate shuttle model (with permission from Bélanger et al., 2011). Glu, glutamate; Gln,
glutamine; GluR, glutamatergic receptor; EAATs, excitatory amino acid transporters; GLUT, glucose transporter; MCTs, monocarboxylate transporters; LDH, lactate
dehydrogenase; GS, glutaminase; GLS, glutamine synthetase.
This gradient exists since concentrations of glucose in plasma
and CSF are approximately 5 mM (Psychogios et al., 2011) and
3 mM (Wishart et al., 2008) respectively, with a CSF:plasma
glucose ratio typically being approximately 0.4–0.8 (Leen et al.,
2012). GLUT1 is specific to astrocytes and cerebral blood vessels,
GLUT3 is exclusively localized at neurons, and GLUT5, primarily
a fructose transporter, is found in microglia (Vannucci et al.,
1997).
Other important regulating proteins in neuroenergetics are:
pyruvate dehydrogenase, the rate-limiting enzyme that catalyzes
lactate oxidation in astrocytes, with the inactive form being
greater in astrocytes than in neurons (Itoh et al., 2003); lactate
dehydrogenase (LDH), of which isoenzymes are found to be
specific to astrocytes (LDH–5: associated with glycolysis) and
neurons (LDH–1: associated with oxidative metabolism) (Bittar
et al., 1996; Laughton et al., 2000); and monocarboxylate
transporters (MCTs), proton-linked transporters of lactate with
localization of subtypes MCT2 to neurons (with high affinity for
lactate) and MCT1 and MCT4 to blood vessels and astrocytes,
respectively (with lower affinity for lactate) (Bergersen, 2007).
The kinetics of these regulating proteins supports the concept
of a flux of lactate from astrocyte to neuron. Most recently in
literature there has been renewed vigor in the research in the
role of MCTs (Bourgeois et al., 2016; Chaumeil et al., 2016;
Karagiannis et al., 2016; Kolko et al., 2016; Lee and Kang,
2016; Pérez-Escuredo et al., 2016; Rosafio et al., 2016). Hence,
we are entering an era in science whereby we are recognizing
that understanding not only shuttles, but the means by which
shuttles operate—transporters (e.g., MCTs), are integral toward
unraveling new information of the complex dynamic processes
found in neuroenergetics.
Astrocytes are therefore viewed as “lactate sources” supplying
the extracellular lactate pool, and neurons as “lactate sinks”
consuming lactate oxidatively in response to energy demands.
The transfer of lactate from astrocyte to neuron can be viewed
as a spatially and temporally independent process (Pellerin and
Magistretti, 2004). Thus, the metabolic plasticity of astrocytes
is likely to be associated with synaptic plasticity (Magistretti,
2006).Magistretti (2000, 2009) sums up the ANLSmodel in terms
of neurometabolic coupling in which sodium-coupled uptake
of glutamate by astrocytes activates Na+-K+-ATPase, which
triggers glucose uptake and its glycolytic processing. This results
in the production and release of lactate that is used by neurons
for activity-dependent energy demands. It has become generally
accepted that lactate is a pivotal component in neuronal brain
energy homeostasis (Schurr et al., 1999a; Pellerin, 2003, 2010;
Gladden, 2004; Schurr, 2006; van Hall et al., 2009).
Controversy Surrounding the ANLS
Hypothesis–Is this the New Paradigm?
Since its introduction, the ANLS has received much attention,
some of which criticizes and refutes the concept; however,
substantial evidence has accumulated from independent sources
that supports the model. Based on in vitro and in vivo
studies (Kuhr and Korf, 1988; Pellerin et al., 2002, 2007;
Itoh et al., 2003; Smith et al., 2003; Pellerin and Magistretti,
2004; Hashimoto et al., 2008; Sampol et al., 2013), there
exists experimental evidence that neurons use lactate derived
from astroglial metabolism efficiently as energy substrates
to preserve normal neuronal function. The lactate shuttle
concept at the core of the ANLS was further supported by
studies on the critical role of glutamate transporters (Pierre
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et al., 2000; Voutsinos-Porche et al., 2003) and distribution
of MCTs in the brain (Pierre et al., 2000; Chiry et al.,
2008; Erlichman et al., 2008; Robinet and Pellerin, 2011),
particularly for long-term memory formation (Suzuki et al.,
2011).
Molecular mechanisms provide further in vitro evidence
that supports the ANLS hypothesis (Bliss et al., 2004; Porras
et al., 2004), showing that upregulation of glycolysis in
neurons decreased oxidation of glucose through the pentose
phosphate pathway, resulting in impaired regeneration of
reduced glutathione, and subsequently oxidative stress and
apoptotic death. Thus, neurons downregulate glycolysis in
order to use available glucose to maintain antioxidant status
(a neuroprotective mechanism) at the expense of its use for
bioenergetics purposes. Neuroenergetic demands can be met by
other sources, such as lactate (Tabernero et al., 1996; Herrero-
Mendez et al., 2009).
Rouach et al. (2008) demonstrated in vitro the change in
character of astrocyte metabolic networks in response to local
energy demand and trafficking of energetic metabolites from
blood vessels, through astrocytes, to distal neurons. Using
13C-NMR, this metabolic flux of lactate from astrocyte to
neuron can be measured noninvasively in the human brain
(Bouzier-Sore et al., 2003; Gallagher et al., 2009; Boumezbeur
et al., 2010). Plasma lactate supports up to 10% of brain
energy metabolism under physiological conditions, and up
to 60% under supra-physiological conditions. Mathematical
modeling studies have also described these dynamics, in
particular brain lactate kinetics (Aubert et al., 2005) and
compartmentalization of brain energy metabolism (Aubert and
Costalat, 2005). However, as stated by Pellerin et al. (2007):
“[mathematical modeling] ... can give a coherent, quantitative
framework for the discussion, suggest possible mechanisms
or, conversely, emphasize the contradictions or implausibility
or some hypotheses.” An example of the argument about
the possible ambiguity of mathematical modeling is given
by Genc et al. (2011). This sentiment is further expressed by
Jolivet et al. (2010): “mathematical models are very powerful
tools but they are ultimately only partial replicas of the
system they model, not the system itself.” Thus, mathematical
models are useful guides but one should be mindful to draw
definitive conclusions based on modeling studies alone. Jolivet
et al. (2010) commented on two mathematical studies of
hypotheses of opposing lactate flux in neuroenergetics—they
compared the mathematical model of ANLS by Aubert et al.
(2007) and the neuron-to-astrocyte lactate shuttle (NALS) by
Mangia et al. (2009). Jolivet et al. (2010) concluded that the
Aubert (ANLS) model currently remains the best biophysical
representation of neuron–astrocyte metabolic interactions.
Further multi-timescale mathematical modeling by Jolivet
et al. (2015) has since provided further support for the ANLS
hypothesis.
While less vocal, there remains strong opposition to the
ANLS hypothesis, with various studies expressing divergent
views. Dienel and Hertz (2001) emphasized the paradox of
intense production of lactate by the brain and the slow rate
of its uptake, thus disagreeing that lactate is used as a major
neuronal fuel. Dienel and Cruz (2003, 2004) further argued that
cerebral metabolic rates of oxygen consumption do not equal
that of glucose plus glycogen and that this disproportionate
consumption is strong evidence against stoichiometric transfer
of lactate from astrocytes to neighboring neurons for oxidation.
Gjedde et al. (2002) averred that, based on their experimental
evidence, changes in metabolism in afferent phase (activity
involving presynaptic terminals and astrocytes) and efferent
phase (activity involving neurons) are additive. This view
opposed the idea that changes in metabolism are characterized
by significant transfer of lactate from astrocyte to neurons.
Gjedde et al. (2002) conclude that there is no suggestion
that astrocytic glycolysis supports oxidative metabolism of
neurons in the baseline condition. Instead, neurons increase
their oxidative metabolism in parallel with a rise in pyruvate
generated by neuronal rather than astrocytic glycolysis (Gjedde
and Marrett, 2001). Mangia et al. (2003a) discussed various
ambiguities from other studies and conclude that astrocyte
activation supports only the glutamate–glutamine cycle and
that neurons primarily metabolize directly absorbed glucose to
support neuronal activity. This behavior is demonstrated by an
initial dip in lactate concentrations following visual stimulation
(Mangia et al., 2003b). As mentioned above, Mangia et al.
(2009) also proposed a model of opposite flux to the ANLS,
namely the NALS hypothesis which utilized the mathematical
model introduced by Simpson et al. (2007), suggesting that
depending on the thermodynamic and kinetic status of the
cytosolic and mitochondrial redox states, lactate transfers from
neurons to astrocytes. The directionality of the ANLS hypothesis
(i.e., lactate from astrocytes to neurons), has been covered
in many reviews. However, the other perspective of shuttling
direction (i.e., from neurons to astrocytes) is an intriguing one,
albeit without substantiated experimental proof of the NALS,
beyond modeling. Other divergent views come from studies
by, for example, Bak et al. (2006), who suggested that synaptic
activity does not induce corresponding upregulation of lactate
metabolism in neurons; DiNuzzo et al. (2010a), who suggested
that carbon recruitment by neurons relies upon glucose uptake
rather than that of a lactate shuttle, and that glycogenolysis in
astrocytes preserves glucose availability for neurons (DiNuzzo
et al., 2010b).
Others have critically reviewed the ANLS hypothesis in
defense of the traditional role of neuroenergetics (Chih et al.,
2001; Chih and Roberts, 2003). Pellerin and Magistretti (2011)
not only addressed all these divergent views by reviewing
experimental evidence supporting the main tenets of the
ANLS model, but also were able to confute several unfounded
criticisms. With overwhelming support for the ANLS hypothesis,
it was becoming clear that lactate is a crucial element in
neuronal brain energy homeostasis (Schurr et al., 1999b;
Pellerin, 2003, 2010; Gladden, 2004; Schurr, 2006; van Hall
et al., 2009). However, as is the case in science, refuting
evidence continues to challenge the foundations of the ANLS
hypothesis, leading to it being redefined and strengthened
over time. The tenets of this hypothesis continue to hold,
begging the question—is this the new paradigm for homeostatic
neuroenergetics?
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NEUROPATHOLOGY AND THE HUMAN
RESPONSE
Beyond Homeostasis
Biological processes maintain stability, by detecting
environmental (external) and physiological (internal) changes,
and activating specialized adaptive responses. The dynamic
metabolic characteristics of astrocytes lend them to being
particularly adept at such a task within the neuronal framework
of homeostasis. Beyond homeostasis lies the comparatively new
concept of allostasis. Allostasis is an extension of the concept of
homeostasis and refers to the maintenance of stability by means
of robust, energy-demanding adaptive mechanisms in response
to severe physical, psychosocial or environmental challenges.
Homeostasis involves maintaining a stable internal environment
of an organism (i.e., by means of a feedback mechanism),
whereas allostasis is more dynamic in that it involves the
continuous response to physiological needs, resulting in
biochemical adaptive mechanisms. These two concepts seem
similar and are not intended to operate independently; instead,
allostasis supports homeostasis, placing emphasis on flexible
adaptation with the ultimate goal of maintaining a stable internal
environment (McEwen, 2006, 2008; Logan and Barksdale,
2008; McEwen and Gianaros, 2011; Danese and McEwen,
2012). Frequent or chronic challenges (e.g., neuroinflammation)
produce dysregulation of several major physiological systems
by triggering chemical mediators of adaption that operate in a
nonlinear network. The cumulative “wear and tear” associated
with the inability to disengage these physiological systems is
referred to as allostatic load. In vulnerable biological systems an
allostatic overload prevails that results in the development of
disease.
Since the term was first coined, by Sterling and Eyer
(1988), the concept of allostasis has primarily been used in the
literature to describe mild perturbations that are stress related,
psychosomatic and/or psychopathological (Tannenbaum et al.,
2002; Stewart, 2006; Shannon et al., 2007; Logan and Barksdale,
2008; Blair et al., 2011; Danese and McEwen, 2012; Tomiyama
et al., 2012). As a concept allostasis is still being developed
and so is gradually being applied to more diverse fields, such
as metabolic diseases and lipidomics (Oresic et al., 2008) and
metabolomics (Ramautar et al., 2013). Allostasis has also been
used to explain extreme glucose fluctuations as reflecting the
body’s inability to cope with allostatic load in the case of chronic
illness, predisposing the individual to serious harm as manifested
by heightened mortality (Stumvoll et al., 2003, 2004; Rake et al.,
2010).
Herein this review the typology, as given by Peters and
McEwen (2015) to describe cardiovascular disease, has been
adapted to define terms in neuroenergetics. Stress occurs in
a state of increased cerebral energy demand to safeguard an
individual’s physical, mental and social well-being. A reversible
stress response distinguishes allostasis from homeostasis and can
be indicated by a relief result (restored homeostasis) in which the
individual returns toward physiological normality. An allostatic
load is indicated by an acute stress challenge—an irreversible or
nearly irreversible state of allostatic stress from homeostasis—as
seen in severely elevated CSF lactate in acute, physical damage to
the brain (Gallagher et al., 2009). Chronic cases of persistently
highly elevated CSF lactate and lactate:pyruvate ratios would
be parameters to define the transition of allostatic load toward
allostatic overload (disease).
Thus, allostasis encompasses typical dynamic adaptations to
transient stress mediators; allostatic load pertains to an acute
state of persistent perturbation and, ultimately, circumstances
of allostatic overload are associated with disease and the body’s
inability to cope. These terms are henceforth discussed in terms
of neuropathological conditions, with the focus on lactate and its
shuttles.
Microglia–Addressing Neuronal Allostasis
Under pathological conditions, such as caused by infection,
the brain enters a state of allostasis and microglia become
activated. Microglia are immunocompetent cells that act as the
intrinsic macrophages of the brain, bearing multiple similarities
to those of macrophages in peripheral tissues. Some of the shared
functions include phagocytosis, antigen presentation, effector
inflammatory response and production of various cytotoxins and
cytokines. Thus, microglia are an important component of both
the innate and adaptive immune response to central nervous
system (CNS) pathogens (Olson andMiller, 2004). They populate
the entire brain parenchyma with a homogeneous distributed
network with territorial organization and act as the first and only
line of defense in the brain.
Under physiological conditions microglia exist in a
resting (“ramified”) state characterized by a small soma
and numerous thin, branched processes (Giaume et al.,
2007). Microglia remain quiescent until activated upon by
brain insult (i.e., injury, disease or infection), characterized
by proliferation and immunophenotypical (expression of
various surface markers and ion channels) and morphological
(transformation to amoeboid morphology) changes (Eder,
1998). The response of microglia to brain insult is first to
detect the site of assault by constant dynamic monitoring of
the surrounding micro-environment, and then to send out
process extensions toward the lesion site where process tips
reorganize to confine, control and eliminate the source of the
disturbance.
Neuroinflammation, the reaction of surrounding brain tissue
to brain insult, is characterized by synthesis of various
inflammatory mediators and reactive gliosis, associated with
phenotypic changes and proliferation of glia (both astrocytes and
microglia), in response to a dynamically changing environment
(Giaume et al., 2007). The modified phenotype of astrocytes,
from basal to reactive state, results in them abandoning their
neuroprotective role, allowing excessive oxidative stress and
production of ROS, and subsequently ROS-induced neuronal
damage (Pellerin, 2003). Chronic neuroinflammation, the
response to sustained and widespread stimuli, typically occurs
due to either disease (e.g., Alzheimer’s and multiple sclerosis)
or persistent infection by viruses (Olson et al., 2001; Ovanesov
et al., 2008) or bacteria (e.g., chronic meningitis as in TBM).
The role of microglia in CNS infections was extensively reviewed
by Rock et al. (2004). Hence, metabolic coupling of microglia
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is essential during neuronal allostasis, especially in response to
pathogens.
THE BRAIN IN CRISIS
Allostatic Load–Physical Brain Trauma
The topic of traumatic brain injury (TBI)—acute, physical
damage to the brain—gained notoriety in 2009 when Jeanne
Marie Laskas wrote an article titled “Game brain” in GQ
magazine (Laskas, 2009), exposing the hidden, negative medical
implications within some popular, professional contact sports. In
2015 this was expanded into a book (Laskas, 2015) and a film
called “Concussion,” about forensic pathologist Bennet Omalu
and his attempts to publicize his scientific findings regarding
physical contact sports (such as in the National Football
League, the apex of American football). Omalu postulated that
persistent mild TBI leads to chronic traumatic encephalopathy.
Consequently, there has been renewed research into concussion
and TBI (Sone et al., 2016; Sussman et al., 2016), making it
another hot topic in neuroscience.
It is well recognized that there is an elevation of brain
extracellular lactate and the lactate:pyruvate ratio in TBI cases
(Gallagher et al., 2009). The group of Gallagher et al. (2009)
and Carpenter et al. (2014) presented direct evidence of brain
utilization of lactate in TBI cases by administration of 13C-labeled
lactate via a microdialysis catheter and using 13C-NMR analysis.
Based on these studies, Carpenter et al. (2015) suggested that
where neurons are too damaged to use the lactate produced
from glucose by astrocytes (i.e., by uncoupling of neuronal
and glial metabolism), high extracellular levels of lactate would
accumulate—explaining the association between high lactate and
poor outcome. Thus, therapeutic intervention before metabolic
uncoupling is imperative. Glucose administration after TBI
has been shown to be beneficial but there is a correlation
between hyperglycemia and increased infection or mortality;
hence, alternative sources of energy, such as lactate, may improve
outcome (Moro et al., 2013). However, as with the ANLS model,
there are opposing opinions of the notion that lactate is a
preferential fuel in TBI cases (Dienel, 2014).
Acute administration of exogenous fuels, such as lactate, after
experimentally induced TBI in rats has been shown to attenuate
histopathology and improve outcome (Chen et al., 2000). In
two companion reports by Glenn et al. (2015a,b), evidence was
provided that central venous tracer infusion of both glucose
and lactate showed massive mobilization of mainly lactate—
systematic lactate was preferentially being directly consumed
and used by TBI cases. Thus, there is a high production and
clearance rate of lactate in TBI cases. The role of this lactate
in cerebral metabolism following TBI and the advantages of
treatment by exogenous lactate infusions was reviewed by Brooks
and Martin (2015). In recent clinical trials of TBI, and other
neurocritical care cases, the beneficial properties of hypertonic
lactate have been observed with respect to cerebral blood flow and
intracranial pressure (Bouzat and Oddo, 2014; Patet et al., 2016).
Thus, accumulating evidence points to lactate being an important
component used during allostatic load caused by acute, physical
damage to the brain—a therapeutic target.
Allostatic Overload–Neurodegenerative
Diseases
A common trait among neurodegenerative diseases is perturbed
brain energy metabolism (Magistretti and Pellerin, 1996; Beal,
2000; Bélanger et al., 2011; Albanese et al., 2016). Huntington’s
disease and multiple sclerosis have been linked to mitochondrial
dysfunction, and so are susceptible to oxidative stress and
energy deficits (Dutta et al., 2006; Regenold et al., 2008; Sack,
2010; Gouarné et al., 2013); with implications of perturbed
lactate levels. In contradiction, two 1H-NMR studies found
conflicting results regarding lactate in Huntington’s disease.
An 1H-NMR investigation by Gårseth et al. (2000) reported
decreased levels of lactate, which they attributed to neuronal
loss, but based upon only a small sample (n = 7). Another
1H-NMR study, by Verwaest et al. (2011), found lactate to
be significantly increased, but this result was also based on
a small sample (n = 10). In a more comprehensive study,
Gouarné et al. (2013) used cultured neuronal subpopulations
from transgenic mice and provided evidence that neurons
use lactate, along with pyruvate, as an energy source to
support respiration. The importance of lactate was corroborated
by a study (Covarrubias-Pinto et al., 2015) on Huntington’s
disease (HD) using ascorbic acid to inhibit use of neuronal
glucose—showing the favoring of lactate uptake to sustain brain
activity. Hence, experimental evidence is emerging that lactate
is important and used preferentially as an energy source in HD
cases.
Two reviews on neurodegenerative diseases support the ANLS
hypothesis and its role in neuropathology—namely, lactate is
neuroprotective and a therapeutic agent. A review by Newington
et al. (2013) refers to their previous scientific work, which
showed that increased lactate production proved to be protective
against Aβ-induced neuronal toxicity that is inherently associated
with Alzheimer’s disease. A review by Finsterwald et al. (2015)
summarizes numerous studies involving astrocytic lactate in
treatments for multiple neurodegenerative diseases [Alzheimer’s,
Parkinson’s disease and amyotrophic lateral sclerosis (ALS)].
Finsterwald et al. (2015) concluded that astrocytic function
elicits intrinsic neuroprotective properties through, amongst
others, the ANLS mechanism. One could go one step further
and speculate that a “specialized” type of ANLS mechanism is
necessary.
In multiple sclerosis (MS) there have been reports of the
importance of CSF lactate. A negative correlation between the
presence of lactate and the presence of inflammatory plaques
and MS severity has been experimentally shown (Lutz et al.,
2007; Albanese et al., 2016)—increased lactate in MS cases
without plaques and vice versa, suggesting close metabolic
coupling between plaque activity and lactate production. A
gene expression study by Zeis et al. (2015) revealed alterations
(downregulation) in the ANLS mechanism in MS, such that
alternative lactate shuttle systems may be at play. Indeed,
other studies have proposed such shuttle systems to supply
demyelinated axons with lactate as an important energy source—
namely, the astrocyte-axon lactate shuttle (Cambron et al., 2012;
Nijland et al., 2015) and the oligodendrocyte-axon lactate shuttle
(Campbell et al., 2014).
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A common thread seen in these studies of neurodegenerative
diseases is the perturbation of lactate. Evidence in
neuropathophysiological cases indicates that lactate acts as
an important, sometimes preferential, source of energy, and
also has neuroprotective properties. The role of lactate shuttle
systems is also emerging as being vital—imperative as supply and
demand needs fluctuate to extremes in situations of allostatic
overload. This is when normal physiological systems can no
longer provide the required resources and/or effects. It is,
however, important to note that neuropathologically activated
astrocytes, as well as other glial cells, such as microglia, may
support mechanisms, such as neuroinflammation, aggravating
neuronal degeneration (Li et al., 2011). The dynamics behind
addressing neuroinflammation caused by an invading pathogen
involves the use of microglia.
In the remainder of this review an adaptation of the ANLS
model—the AMLS model (Mason et al., 2015)—is discussed in
terms of TBM; a chronic, infectious neuroinflammatory disease.
Pathogen-Induced Chronic
Neuroinflammation
In the case of a chronic infection in the brain by a persistent
pathogen, such asMycobacterium tuberculosis (Mtb), the bacillus
responsible for TBM, there is sustained allostatic overload. Here,
the microglia strive to eradicate the scourge but unwittingly
become the habitat of the persisting pathogen. Similar to the
ANLS hypothesis, the AMLSmodel proposes that when the brain
is in crisis due to infection, energy flow in brain metabolism is
shifted away from the neurons, and shunted toward the microglia
(see Figure 2). The initial mechanics of the AMLS remain the
same as the ANLS, the only difference being the directionality
of the lactate upon exiting the astrocyte. The AMLS hypothesis
postulates that in neuroinflammatory infectious diseases, such
as TBM, lactate produced through glycolysis in astrocytes
participates in the activated immune response and, in association
with ketones and gluconeogenic amino acids, is collectively
directed from the neurons preferentially into microglia. Within
the microglia, lactate is expected to enter the mitochondrial
Krebs cycle, contributing to oxidative phosphorylation and hence
producing high levels of ATP and forms of ROS, such as
hydrogen peroxide, required for degradation of the invading
pathogen. Thus, the AMLS hypothesis uses the same line of logic
of the ANLS model, but instead the microglia are the prime
focus under conditions of neuroinflammatory infectious diseases;
increased astrocytic lactate is directed toward the microglia.
Using the same CSF samples from the study by Mason et al.
(2015), it was shown in a targeted analysis (Mason et al., 2016a)
that the highly elevated amounts of lactate observed in the CSF
of confirmed TBM cases was only in the L-form (L-lactate is
produced by the host, whereas D-lactate is of bacterial origin).
Thus, elevated lactate found in the CSF of TBM cases is solely
a response by the host to the infection. These results from this
follow-up study by Mason et al. (2016a) provide experimental
evidence to support the proposed AMLS model and highlight the
fact that lactate plays an important role in neuroinflammatory
diseases, such as TBM. Activation of microglia, as required in
the AMLS hypothesis, does not, however, present a uniform
process and involves intricate interactions and feedback loops
between the microglia, astrocytes and neurons that hamper
attempts to construct basic and linear cascades of cause and
effect; TBM involves a complex integration of the responses from
the various cell types present within the CNS, with microglia and
the astrocytes as main players.
During the course of a neuroinflammatory infectious disease,
such as TBM, the ANLS is not only inadequate but, indeed,
a liability as activated neurons will only become vulnerable
to neurodestructive components. The bypassing of metabolic
energy intermediates from the neurons effectively inactivates
them to protect them fromneurodestructive agents in response to
chronic neuroinflammation. This neuron inactivation is evident
from a clinical viewpoint as the progression of TBM is reflected
by reduced scoring in the Glasgow Coma Score—specifically,
decreased consciousness and awareness. The AMLS hypothesis
can thus be viewed as invoking a persistent allostatic overload
state that becomes activated when allostatic mechanisms fail and
the body enters into a diseased state. The regulation of dynamic
systems that function within the brain, in terms of homeostasis,
allostasis and disease states, is delicate. Chronic activation of
microglia can lead to neuropathological sequelae (Streit et al.,
2004), and is also linked to neuropathic pain (Raghavendra et al.,
2003). The persistent activation of microglia can be viewed as
the proverbial double-edged sword—simultaneously exhibiting
neuroprotective and neurodestructive properties in an attempt to
save the whole at the expense of the part (Hall et al., 1998; Giaume
et al., 2007).
Using TBM as an example of an infectious neuroinflammatory
disease—an extreme scenario of allostatic overload—it can be
speculated that the Mtb-induced host and microbe markers can
reflect: (1) the disease state on admission to hospital, and (2)
differentiation in the restoration toward a new condition of
homeostasis following treatment. Upon admission to hospital,
most TBM patients present with moderate to severe symptoms
of ketosis. Metabolomics analysis of the urine (Mason et al.,
2016b) substantiates this clinical picture through a ketosis
urinary biosignature—cases admitted to hospital with very high
ketosis biomarkers tended to have a poor prognosis, leading
to severe neurological complications irrespective of treatment.
A similar profile was also reflected in the CSF biochemistry
(Mason et al., 2016a); as the TBM disease progressed into
its later stages there was a deterioration in patient prognosis.
Hence, in more advanced TBM stages there is less CSF lactate
and therefore fewer energy substrates available for microglia
activity, and decreased protection of neurons. During this period,
irreversible neurological damage can begin to occur—illustrating
the importance of lactate levels during periods of chronic
neuroinflammation.
The concept of lactate shuttle systems extends to other types
of neuronal cells, such as the oligodendrocyte–axon lactate
shuttle (Baltan, 2015) and the Bergmann glia (BG) Purkinje
cell (PC) lactate shuttle (Sawada et al., 2016). Lactate shuttles
extend beyond the brain—they are of particular interest in
cancer research (Pizzuto et al., 2012). Several cancer studies have
suggested a tumor-to-stroma coupling via a lactate shuttle in
Frontiers in Neuroscience | www.frontiersin.org 8 February 2017 | Volume 11 | Article 43
Mason Neuro(patho)physiological Lactate Shuttles
FIGURE 2 | Representation of metabolic pathways of two lactate shuttles within the central nervous system. (1) The astrocyte–neuron lactate shuttle
(ANLS; green pathway) operates under normal physiological conditions with astrocytes responding to glutamatergic activation by increasing their rate of glucose
utilization and release of lactate in the extracellular space, making the lactate available for neurons to sustain their energy demands. (2) The astrocyte–microglia lactate
shuttle (AMLS; red pathway) proposed for tuberculous meningitis (TBM). Astrocytes respond to signaling from Mycobacterium tuberculosis (Mtb)-infected microglia by
increasing glucose mobilization, leading to increased extracellular lactate, reflected in increased cerebrospinal fluid (CSF) lactate levels. Lactate used by microglia as
an additional energy source for reactive oxygen species (ROS) production aimed at destroying the invading Mtb.
cancer cells (Pértega-Gomes et al., 2014; Sanità et al., 2014).
These studies indicate that over-propagation of cells is strongly
dependent upon the anaplerotic role of increased lactate uptake
(Whitaker-Menezes et al., 2011; Fiaschi et al., 2012). This
concept is supported by a large-scale in silico metabolic model
(Capuani et al., 2015). Interestingly, Somashekar et al. (2011)
stated that their most relevant metabolic observations in studying
tuberculosis are similar to metabolic changes seen in cancer
during tumor development—corroborated by Zhou et al. (2015).
Conceptually, the “Reverse Warburg Effect” (Pavlides et al.,
2009), proposed as operating in tumor cells, has been interpreted
to be analogous to the astrocyte–neuron metabolic coupling
(Pavlides et al., 2010), where the astrocytes resemble cancer-
associated fibroblasts and the neuron the epithelial tumor cells,
resulting in their higher proliferative capacity.
The regulation of lactate shuttles has been discussed as being
a potential therapeutic target in cancer research (Draoui and
Feron, 2011; Sanità et al., 2014). While disruption of transport
of lactate into cancerous cells (i.e., reducing lactate shuttling
into cancerous cells) is considered beneficial, upregulation
in neuropathological cases shows merit for research. Several
studies have demonstrated that intracerebroventricular or
intravenous injection of lactate yields a neuroprotective effect
during experimentally induced hypoglycemia or cerebral
ischemia (Berthet et al., 2009, 2012; Wyss et al., 2011). In
addition, other experimental work (Yamanishi et al., 2006;
Gordon et al., 2008) has shown that lactate increases cerebral
blood flow (vasodilation)—increasing the supply of metabolic
(e.g., energy) substrates during allostasis. Thus, lactate has
a potentially beneficial role in the clinical management
of several neurological disorders (Taher et al., 2016). This
review, like the others cited here, therefore shows that further
research into the role of lactate and its shuttling mechanism(s)
are certainly warranted to address neuroenergetics and
neuropathology.
CONCLUDING REMARKS
In summary, we are seeing the prevailing school of thought
moving away from the neurocentric paradigm, albeit with
divergent views, toward that of one that is more integrated.
Within this emerging new paradigm, an unraveling of the
intricacies of the complex and diverse dynamic interactions of
the human brain at the metabolic and cellular levels is occurring.
Our current knowledge has led us to the realization that lactate
shuttle systems, both intracellular and extracellular, play a far
more pivotal role than originally considered. Indeed, there exist
numerous other shuttles in neuroenergetics—for example: the
lactate–alanine shuttle (Zwingman et al., 2000); the astrocyte–
neuron ketone body shuttle (Guzmán and Blázquez, 2001); the
glycerol phosphate shuttle (McKenna et al., 2006); and the
malate–aspartate shuttle (McKenna et al., 2006; Moffett et al.,
2013). Each in its own right is essential in terms of both
homeostasis and allostasis. It is evident that transitions between
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different states of homeostasis and allostasis, and disease, are
dynamic—they are often difficult to distinguish and/or control.
However, the role of neuroenergetics is undeniable in the
brain’s constant objective of protecting itself and trying to
maintain an optimum state. Here, we have discussed, in terms
of neuroenergetics, the role of lactate in a shuttle system during
homeostasis (ANLS) and in the infected state (AMLS). Other
studies on neurodegenerative diseases have described complex
pathophysiological changes that highlighted the importance of
lactate (Newington et al., 2013; Finsterwald et al., 2015). There
is thus overwhelming evidence that astrocytes, lactate and the
associated shuttle systems so far recognized in combination are of
crucial importance in neuroenergetics—in both the healthy and
diseased state. Perhaps not surprisingly, the latest technology has
revealed that neuro(patho)physiological metabolism is far more
complex than originally thought and that further knowledge
of the lactate shuttle systems apparently operating, as outlined
in this article, is key to our understanding of the mechanisms
involved.
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